Rodère, Malory http://orcid.org/0000-0002-3669-7132
Pereira, Bruno http://orcid.org/0000-0003-3778-7161
Soubrier, Martin http://orcid.org/0000-0001-9349-0720
Fayet, Françoise http://orcid.org/0000-0002-5491-2262
Piperno, Muriel http://orcid.org/0000-0002-0786-3752
Pallot-Prades, Béatrice
Pouplin, Sophie http://orcid.org/0000-0002-5797-4813
Baudens, Guy
Cohen, Jean-David http://orcid.org/0000-0003-0636-9653
Coquerelle, Pascal http://orcid.org/0000-0002-8475-8518
Grange, Laurent http://orcid.org/0000-0002-3288-2015
Sordet, Christelle http://orcid.org/0000-0001-6382-8735
Tropé, Sonia http://orcid.org/0000-0002-7321-9287
Gossec, Laure http://orcid.org/0000-0002-4528-310X
Beauvais, Catherine http://orcid.org/0000-0002-9872-4298
Funding for this research was provided by:
Centre hospitalier Universitaire de Clermont-Ferrand (AOI 2016)
Article History
Received: 9 November 2021
Accepted: 1 January 2022
First Online: 7 April 2022
Declarations
:
: None of the authors has any conflicts of interest to declare related to this study.
: The study was approved by Clermont-Ferrand (France) Advisory Committee on Information Processing in Material Research in the Field of Health N° 15 863 and the French national data protection agency. Patients received oral and written information on the objectives of the study and signed informed consent before entering the study.
: Catherine Beauvais: research grants from BMS, Fresenius Kabi, Lilly, Mylan. Advisory board: Novartis and Sandoz. Occasional speaker fees from BMS, Abbvie, MSD, Mylan, Pfizer, Roche, Sanofi, and UCB. Christelle Sordet reports occasional consulting fees from Abbvie, UCB, Lilly, Nordic, GSK, Roche Chugaï, and BMS. Laure Gossec reports research grants from Amgen, Galapagos, Janssen, Lilly, Pfizer, Sandoz, Sanofi and consulting fees from AbbVie, Amgen, BMS, Biogen, Celgene, Galapagos, Gilead, Janssen, Lilly, Novartis, Pfizer, Samsung Bioepis, Sanofi-Aventis, and UCB.
: Deidentified participant data will be available upon request by contacting the principal investigator Malory Rodère <u>mrodere@chu-clermontferrand.fr</u> and/or the Data manager Bruno Pereira MD PhD <u>bpereira@chu-clermontferrand.fr.</u> Reuse of data is permitted with a signed data access agreement.